Cargando…

Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver Metastasis

SIMPLE SUMMARY: Approximately 25% of patients with colorectal cancer will present with or develop colorectal liver metastasis (CRLM). Surgical resection of CRLM offers these patients the best chance of a cure. However, liver resection and the subsequent regenerative response has been linked to tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riddiough, Georgina E., Fifis, Theodora, Walsh, Katrina A., Muralidharan, Vijayaragavan, Christophi, Christopher, Tran, Bang M., Vincan, Elizabeth, Perini, Marcos V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199217/ https://www.ncbi.nlm.nih.gov/pubmed/34073112 http://dx.doi.org/10.3390/cancers13112734

Ejemplares similares

Captopril, a Renin–Angiotensin System Inhibitor, Attenuates Tumour Progression in the Regenerating Liver Following Partial Hepatectomy
por: Riddiough, Georgina E., et al.
Publicado: (2022)

Immunomodulatory effects of renin–angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases
por: Vallejo Ardila, Dora Lucia, et al.
Publicado: (2020)

Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity
por: Vallejo-Ardila, Dora L., et al.
Publicado: (2018)

SAR131675, a VEGRF3 Inhibitor, Modulates the Immune Response and Reduces the Growth of Colorectal Cancer Liver Metastasis
por: Walsh, Katrina A., et al.
Publicado: (2022)

Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases
por: Lin, Wen Xu, et al.
Publicado: (2011)

Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments
por: Nguyen, Linh, et al.
Publicado: (2012)

Laparoscopic treatment of a patent ductus venosus and the use of indocyanine green to monitor perioperative hepatic function
por: Perini, Marcos V, et al.
Publicado: (2018)

The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling
por: Tran, Bang Manh, et al.
Publicado: (2020)

Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis
por: Nguyen, Linh, et al.
Publicado: (2016)

The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model
por: da Costa, Patricia Luiza Nunes, et al.
Publicado: (2018)

Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor
por: Fifis, Theodora, et al.
Publicado: (2013)

Editorial: reducing blood loss in liver transplantation—the impact of surgical technique
por: Perini, Marcos V., et al.
Publicado: (2021)

Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril
por: Senanayake, Preenie deS, et al.
Publicado: (2018)

The Prognostic Significance of Lymphatics in Colorectal Liver Metastases
por: Muralidharan, Vijayaragavan, et al.
Publicado: (2014)

Dilemmas and limitations interpreting carbohydrate antigen 19-9 elevation after curative pancreatic surgery: A case report
por: Gold, Grace, et al.
Publicado: (2018)

Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
por: Kim, Jung Hee, et al.
Publicado: (2016)

Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
por: Neo, Jaclyn H, et al.
Publicado: (2010)

Angiotensin-Converting Enzyme Inhibitor, Captopril, Improves Scar Healing in Hypertensive Rats
por: Rha, Eun Young, et al.
Publicado: (2021)

Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
por: Castelletto, Valeria, et al.
Publicado: (2021)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril
por: Akif, Mohd, et al.
Publicado: (2011)

The value of the post-captopril aldosterone/renin ratio for the diagnosis of primary aldosteronism and the influential factors: A meta-analysis
por: Xiang, Qiao, et al.
Publicado: (2020)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
por: Biyani, Chandra Shekhar, et al.
Publicado: (2020)

Experimental and Molecular Modeling Studies on the Complexation of Chromium(III) with the Angiotensin-Converting Enzyme Inhibitor Captopril
por: Mahmoud, Shimaa A., et al.
Publicado: (2022)

Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice
por: Ito, Aiko, et al.
Publicado: (2023)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Renin Angiotensin system-modifying therapies are associated with improved pulmonary health
por: Soto, Maira, et al.
Publicado: (2017)

The renin–angiotensin system and diabetes: An update
por: Ribeiro-Oliveira, Antônio, et al.
Publicado: (2008)

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN
por: Fischer-Ferraro, Catalina, et al.
Publicado: (1971)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Within the Brain: The Renin Angiotensin System
por: Jackson, LaDonya, et al.
Publicado: (2018)

Renin-Angiotensin System and Cardiovascular Functions
por: Wu, Chia-Hua, et al.
Publicado: (2018)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Role of the Renin-Angiotensin System in ARDS
por: Zambelli, V., et al.
Publicado: (2012)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

Nanoparticle approaches for the renin-angiotensin system
por: Hettiarachchi, Sajini D., et al.
Publicado: (2023)

The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates the Intrarenal Renin-Angiotensin System
por: Kim, Suyeon, et al.
Publicado: (2006)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q470ma8dap0ocmjf2og0qu6ulb